Who published this market news?

TradingView published this market news item.

Polaryx Therapeutics' Lisa Bollinger resigns as Chief Medical Officer

Polaryx Therapeutics announced that Lisa Bollinger, MD, resigned as Chief Medical Officer, effective July 19, 2026.Original SEC Filing: Polaryx Therapeutics, Inc. [ PLYX ] - 8-K - Jul. 21, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with…

Polaryx Therapeutics announced that Lisa Bollinger, MD, resigned as Chief Medical Officer, effective July 19, 2026.

IndividualLisa Bollinger, MD

RoleChief Medical Officer

Type of ChangeResigned

Effective DateJuly 19, 2026

ReasonNot disclosed

Replacement InfoCompany has commenced a search; interim responsibilities assumed by existing leadership team

Background DetailsNot disclosed

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.